These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 37720036

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Distinguishing the effects of systemic CSF1R inhibition by PLX3397 on microglia and peripheral immune cells.
    Okojie AK, Uweru JO, Coburn MA, Li S, Cao-Dao VD, Eyo UB.
    J Neuroinflammation; 2023 Oct 21; 20(1):242. PubMed ID: 37865779
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Concentration-dependent effects of CSF1R inhibitors on oligodendrocyte progenitor cells ex vivo and in vivo.
    Liu Y, Given KS, Dickson EL, Owens GP, Macklin WB, Bennett JL.
    Exp Neurol; 2019 Aug 21; 318():32-41. PubMed ID: 31029597
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Colony-Stimulating Factor 1 Receptor (CSF1R) Regulates Microglia Density and Distribution, but Not Microglia Differentiation In Vivo.
    Oosterhof N, Kuil LE, van der Linde HC, Burm SM, Berdowski W, van Ijcken WFJ, van Swieten JC, Hol EM, Verheijen MHG, van Ham TJ.
    Cell Rep; 2018 Jul 31; 24(5):1203-1217.e6. PubMed ID: 30067976
    [Abstract] [Full Text] [Related]

  • 8. CSF1R inhibition with PLX5622 affects multiple immune cell compartments and induces tissue-specific metabolic effects in lean mice.
    Bosch AJT, Keller L, Steiger L, Rohm TV, Wiedemann SJ, Low AJY, Stawiski M, Rachid L, Roux J, Konrad D, Wueest S, Tugues S, Greter M, Böni-Schnetzler M, Meier DT, Cavelti-Weder C.
    Diabetologia; 2023 Dec 31; 66(12):2292-2306. PubMed ID: 37792013
    [Abstract] [Full Text] [Related]

  • 9. The CSF1R-Microglia Axis Has Protective Host-Specific Roles During Neurotropic Picornavirus Infection.
    Sanchez JMS, DePaula-Silva AB, Doty DJ, Hanak TJ, Truong A, Libbey JE, Fujinami RS.
    Front Immunol; 2021 Dec 31; 12():621090. PubMed ID: 34566948
    [Abstract] [Full Text] [Related]

  • 10. An Early Microglial Response Is Needed To Efficiently Control Herpes Simplex Virus Encephalitis.
    Uyar O, Laflamme N, Piret J, Venable MC, Carbonneau J, Zarrouk K, Rivest S, Boivin G.
    J Virol; 2020 Nov 09; 94(23):. PubMed ID: 32938766
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CSF1R inhibition promotes neuroinflammation and behavioral deficits during graft-versus-host disease in mice.
    Adams RC, Carter-Cusack D, Llanes GT, Hunter CR, Vinnakota JM, Ruitenberg MJ, Vukovic J, Bertolino P, Chand KK, Wixey JA, Nayler SP, Hill GR, Furlan SN, Zeiser R, MacDonald KPA.
    Blood; 2024 Mar 07; 143(10):912-929. PubMed ID: 38048572
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of IL-34 Unveils Tissue-Selectivity and Is Sufficient to Reduce Microglial Proliferation in a Model of Chronic Neurodegeneration.
    Obst J, Simon E, Martin-Estebane M, Pipi E, Barkwill LM, Gonzalez-Rivera I, Buchanan F, Prescott AR, Faust D, Fox S, Brownlees J, Taylor D, Perry VH, Nuthall H, Atkinson PJ, Karran E, Routledge C, Gomez-Nicola D.
    Front Immunol; 2020 Mar 07; 11():579000. PubMed ID: 33162994
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Deplete and repeat: microglial CSF1R inhibition and traumatic brain injury.
    Boland R, Kokiko-Cochran ON.
    Front Cell Neurosci; 2024 Mar 07; 18():1352790. PubMed ID: 38450286
    [Abstract] [Full Text] [Related]

  • 17. Dominant-acting CSF1R variants cause microglial depletion and altered astrocytic phenotype in zebrafish and adult-onset leukodystrophy.
    Berdowski WM, van der Linde HC, Breur M, Oosterhof N, Beerepoot S, Sanderson L, Wijnands LI, de Jong P, Tsai-Meu-Chong E, de Valk W, de Witte M, van IJcken WFJ, Demmers J, van der Knaap MS, Bugiani M, Wolf NI, van Ham TJ.
    Acta Neuropathol; 2022 Aug 07; 144(2):211-239. PubMed ID: 35713703
    [Abstract] [Full Text] [Related]

  • 18. Deletion of a Csf1r enhancer selectively impacts CSF1R expression and development of tissue macrophage populations.
    Rojo R, Raper A, Ozdemir DD, Lefevre L, Grabert K, Wollscheid-Lengeling E, Bradford B, Caruso M, Gazova I, Sánchez A, Lisowski ZM, Alves J, Molina-Gonzalez I, Davtyan H, Lodge RJ, Glover JD, Wallace R, Munro DAD, David E, Amit I, Miron VE, Priller J, Jenkins SJ, Hardingham GE, Blurton-Jones M, Mabbott NA, Summers KM, Hohenstein P, Hume DA, Pridans C.
    Nat Commun; 2019 Jul 19; 10(1):3215. PubMed ID: 31324781
    [Abstract] [Full Text] [Related]

  • 19. Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits.
    Henry RJ, Ritzel RM, Barrett JP, Doran SJ, Jiao Y, Leach JB, Szeto GL, Wu J, Stoica BA, Faden AI, Loane DJ.
    J Neurosci; 2020 Apr 01; 40(14):2960-2974. PubMed ID: 32094203
    [Abstract] [Full Text] [Related]

  • 20. CSF1R antagonism results in increased supraspinal infiltration in EAE.
    Wang M, Caryotakis SE, Smith GG, Nguyen AV, Pleasure DE, Soulika AM.
    J Neuroinflammation; 2024 Apr 20; 21(1):103. PubMed ID: 38643194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.